Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease
- 18 March 2004
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 114 (6) , 581-587
- https://doi.org/10.1007/s00439-004-1107-9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Genetic variation in a haplotype block spanningIDE influences Alzheimer diseaseHuman Mutation, 2003
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsThe Journal of cell biology, 2003
- The UCSC Genome Browser DatabaseNucleic Acids Research, 2003
- Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's diseaseMolecular Psychiatry, 2002
- β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s diseasePeptides, 2002
- Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trialAnnals of Neurology, 2002
- The HUGO Gene Nomenclature Committee (HGNC)Human Genetics, 2001
- Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasmaAmyloid, 2000
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984